Clearity Perspective: When people like Connie share their ovarian cancer experience, it helps others learn about resources and feel less alone. Connie speaks about how she benefitted from Clearity’s Steps Through OC program by receiving personalized Ovarian Cancer Counseling. Clearity … Read more The post From Educator to Advocate – Connie’s Story appeared first on Clearity Foundation ..read more

by Linda Wang Physical activity can have many benefits for cancer survivors, from improving their quality of life to potentially making it less likely that their disease will come back. Yet studies have shown that many cancer survivors struggle to … Read more The post Program Helps Medically Underserved, Minority Cancer Survivors Be More Active appeared first on Clearity Foundation ..read more

by Charles Bankhead Patients who received protocol waivers in a clinical trial of targeted anticancer therapy had outcomes similar to those who met all enrollment criteria, a large retrospective review showed. Patients who received waivers had a clinical benefit rate … Read more The post Study Supports More Inclusive Clinical Trials With Broader Eligibility Criteria <p>—No difference in adverse events, clinical benefit, OS for patients with or without waivers</p> appeared first on Clearity Foundation ..read more

Clearity’s Perspective: This article is written by a daughter whose mother was diagnosed with advanced ovarian cancer. She shares the story of her mother’s diagnosis and treatment and how her family handled learning of her mother’s inheritable genetic condition. Clearity … Read more The post The best way to prevent this deadly cancer is to remove multiple organs. And I’m about to do it. appeared first on Clearity Foundation ..read more

As presented at the ESMO Gynaecological Cancers Congress 2024 (Florence, 20–22 June), a post-hoc analysis of the phase III MIRASOL (GOG 3045/ENGOT-ov55) trial in patients with high folate receptor alpha (FRalpha), platinum-resistant ovarian cancer revealed that even those who required … Read more The post Platinum-resistant ovarian cancer: mirvetuximab soravtansine benefits are maintained in patients who require dose modifications appeared first on Clearity Foundation ..read more

By Sharon Worcester, MA CHICAGO — Carlos, a 21-year-old, lay in a hospital bed, barely clinging to life. Following a stem cell transplant for leukemia, Carlos had developed a life-threatening case of graft-vs-host disease. But Carlos’ mother had faith. “I … Read more The post One Patient Changed This Oncologist’s View of Hope. Here’s How. appeared first on Clearity Foundation ..read more

Clearity’s Perspective: This article highlights that some people with ovarian cancer who live in certain geographic locations, like rural areas, may get treated at centers with less experience treating ovarian cancer and/or fewer resources to support whole-person needs. Clearity offers … Read more The post Achieving High-Quality Care for Patients With Ovarian Cancer appeared first on Clearity Foundation ..read more

by Wayne Kuznar CHICAGO — Clinical activity and survival outcomes improved with the addition of ipilimumab (Yervoy) to nivolumab (Opdivo) in patients with ovarian or other gynecologic clear cell carcinomas, according to results from the non-comparative phase II BrUOG 354 … Read more The post Dual Immunotherapy Improves Response Rates in Gynecologic Clear Cell Cancers appeared first on Clearity Foundation ..read more

by Silas Inman The addition of atezolizumab (Tecentriq) to single-agent non–platinum-based chemotherapy and bevacizumab (Avastin) did not provide any additional benefits for patients with recurrent ovarian cancer, according to the final analysis of the phase 3 AGO-OVAR 2.29/ENGOT-ov34 study (NCT03353831) … Read more The post No Benefit to Adding Atezolizumab to Chemo/Bevacizumab for Ovarian Cancer appeared first on Clearity Foundation ..read more

by The ASCO Post Staff Some people with advanced epithelial ovarian cancer may safely avoid having their lymph nodes removed during surgery without it impacting their survival outcomes, helping to reduce the risk of postoperative complications. This research was presented … Read more The post Advanced Ovarian Cancer: Can Lymphadenectomy Be Avoided for Some Patients? appeared first on Clearity Foundation ..read more